Development of lichen planus following benralizumab treatment

Eur J Dermatol. 2021 Apr 1;31(2):261-262. doi: 10.1684/ejd.2021.3995.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Anti-Asthmatic Agents / adverse effects*
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Asthma / drug therapy
  • Female
  • Humans
  • Lichen Planus / chemically induced*

Substances

  • Anti-Asthmatic Agents
  • Antibodies, Monoclonal, Humanized
  • benralizumab